Lemonade initiated with an Underweight at Morgan Stanley

Morgan Stanley analyst Bob Huang initiated coverage of Lemonade with an Underweight rating and $14 price target. The company’s path to profitability remains long and the firm sees better risk/reward elsewhere with the stock currently trading at ~3x EV/Revenue with elevated underwriting losses, the analyst tells investors in a research note.